LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
2,590
$85.77
$0.48
(0.56%)
| Watchers | 2,590 |
| 52-Wk Low | $49.24 |
| 52-Wk High | $94.57 |
| Market Cap | $1.53B |
| Volume | 164,727.00 |
| 52-Wk High | $94.57 |
| 52-Wk Low | $49.24 |
Ligand Reports First Quarter 2024 Financial ResultsBusiness Wire • 8 days ago
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates. Ligand...
Share to Feed
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) and Agenus Inc. (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that the...
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report first quarter 2024 financial results after the close of the U.S. financial markets on Tuesday, May 7, 2024, and...
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc. presented new data on Captisol-enabled...
Vanguard Group Inc. reduced its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 0.1% in the 3rd quarter, according to its most recent filing with the Securities and...
A month has gone by since the last earnings report for Ligand Pharmaceuticals (LGND). Shares have lost about 15.5% in that time frame, underperforming the S&P 500.Will the recent negative trend...
Pacer Advisors Inc. lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND Free Report) by 59.1% during the 4th quarter, according to the company in its most recent filing...
Nordea Investment Management AB lessened its holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND Free Report) by 3.3% in the 4th quarter, according to its most recent filing with...
LGND's total volume now sits at 1.2M. The +-1.17% price change was insignificant, leaving IBM's price at $71.09...
This indicator may be signaling that LGND's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...